R1 RCM grows operations with purchase of Cloudmed
R1 RCM announced on January 10, 2022 that it has entered into a definitive agreement to purchase CloudMed for $4.1 billion, including $857 of net debt. R1 intends to use this purchase to enhance its automation capabilities and connect with nearly all of the top 50 healthcare systems. After this news, R1 RCM's stock hit the lowest point in six months, dropping over 12% in 96 hours, though RCM is confident that the transaction will generate $85 million in cost synergies by the end of year three of the deal.
M&AIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.